Cybrdi is a Frederick, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medbox, Inc. develops, sells, and services automated, biometrically controlled dispensing and storage systems for medicine and merchandise applications. Its products comprise Medbox medicine storage machines; safe access storage lockers; Medbox lockbox Rx storage/retrieval systems; Medbox OTC machines; and Medbox Sample-Safe, a wall-mounted unit for use in doctor’s offices. Medbox, Inc. provides its patented systems, software, and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities and medical groups worldwide. The company was formerly known as MindfulEye, Inc. and changed its name to Medbox, Inc. in August 2011. Medbox, Inc. is headquartered in West Hollywood, California.
Biohit is a Neptune, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bovanti is a Fayetteville, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world`s most prevalent eye diseases. The company`s surgical glaucoma product portfolio features the OMNI Surgical System, a dually indicated MIGS device that facilitates the performance of both ab interno trabeculotomy and transluminal viscoelastic delivery. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemm`s canal and collector channels) with a single device and single corneal incision. The company`s non-surgical dry eye product portfolio consists of the TearCare for ophthalmologists and optometrists. TearCare is a software-controlled, wearable, therapeutic eyelid technology designed to melt and clear obstructions of the meibomian glands within the eyelids. Leveraging the full functionality of the blinking eye, proprietary SmartLid™ technology is designed to conform to all eyelid anatomies and achieve therapeutic meibum melting temperatures at the tarsal conjunctiva thereby clearing meibomian gland obstructions while sparing the cornea. Improved meibum production results in a higher quality lipid layer and higher quality tears.